552 Chemoattraction of Pseudomonas aeruginosa PAO1 to bovine bile in a novel, cystic fibrosis-derived bronchial epithelial cell model

PCN before testing, which increased to 69% (9/13) after de-labeling.Conversely, very few antibiotics were PCN in the cohort ineligible for testing, 10% (2/20) before and 12% (2/17) after the survey (Figure 1).No episodes of anaphylaxis occurred.On survey, 80% of families (4/5) were comfortable or very comfortable with PCN use after de-labeling.One child developed a rash while on a PCN, although it is unclear whether it was directly related.No difference was found in the type of bacteria grown before and after the study period in either population.